Growing community of inventors

St. Martin Boulogne sur Mer, France

Thierry Taverne

Average Co-Inventor Count = 4.91

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 31

Thierry TaverneBertrand Leblond (16 patents)Thierry TaverneJohn E Donello (15 patents)Thierry TaverneEric Beausoleil (12 patents)Thierry TaverneRong Yang (5 patents)Thierry TaverneAnne-Sophie Casagrande (4 patents)Thierry TaverneMatthew P Pando (4 patents)Thierry TaverneLaurent Desire (3 patents)Thierry TaverneCedric Chauvignac (3 patents)Thierry TaverneEric Beusoleil (3 patents)Thierry TaverneCédric Chauvignac (2 patents)Thierry TaverneFabien J Schweighoffer (1 patent)Thierry TaverneFabien (Jacques) Schweighoffer (1 patent)Thierry TaverneLaurent Désiré (1 patent)Thierry TaverneSilvère Petit (1 patent)Thierry TaverneVirginie Picard (1 patent)Thierry TaverneThierry Taverne (16 patents)Bertrand LeblondBertrand Leblond (23 patents)John E DonelloJohn E Donello (136 patents)Eric BeausoleilEric Beausoleil (16 patents)Rong YangRong Yang (28 patents)Anne-Sophie CasagrandeAnne-Sophie Casagrande (5 patents)Matthew P PandoMatthew P Pando (5 patents)Laurent DesireLaurent Desire (6 patents)Cedric ChauvignacCedric Chauvignac (3 patents)Eric BeusoleilEric Beusoleil (3 patents)Cédric ChauvignacCédric Chauvignac (2 patents)Fabien J SchweighofferFabien J Schweighoffer (21 patents)Fabien (Jacques) SchweighofferFabien (Jacques) Schweighoffer (1 patent)Laurent DésiréLaurent Désiré (1 patent)Silvère PetitSilvère Petit (1 patent)Virginie PicardVirginie Picard (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Allergan, Inc. (15 from 2,285 patents)

2. Exonhit Therapeutics, Sa (11 from 25 patents)


16 patents:

1. 9902710 - Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)

2. 9828349 - 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity

3. 9670181 - Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)

4. 9399628 - 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity

5. 9278943 - Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds

6. 9200016 - Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)

7. 8927589 - 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-aminopropionic acid amides and related compounds having analgesic and/or immuno stimulant activity

8. 8835463 - Compounds having analgesic and/or immunostimulant activity

9. 8772316 - Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A)

10. 8513288 - 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity

11. 8431599 - 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity

12. 8288556 - 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity

13. 8168631 - 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity

14. 8153666 - Compounds having analgesic and/or immunostimulant activity

15. 8013000 - 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimlant activity

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/13/2025
Loading…